Skip to main content
OpenTrials
Completed

NCT Number: NCT02238275

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Study to evaluate efficacy and tolerability of Micardis® plus under usual daily-practice prescribing-conditions

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult (Age >= 18 years) males and females for whom a medical antihypertensive therapy is indicated

Exclusion criteria

  • Age < 18 years

Treatment and study plan

Micardis® plus

Drug

Primary outcomes

  1. Change from baseline in morning blood pressure

    Time frame: Baseline, after 6 weeks

  2. Change from baseline in classification of blood pressure

    Time frame: Baseline, after 6 weeks

    according to Word Health Organisation - Isolated systolic hypertension (WHO-ISH) - definition of 'Deutsche Hochdruckliga'

Secondary outcomes

  1. Number of patients with adverse drug reactions

    Time frame: up to 6 weeks

  2. Assessment of efficacy by investigator on 5-point scale

    Time frame: after 6 weeks

  3. Assessment of tolerability by investigator on a 5-point scale

    Time frame: after 6 weeks

  4. Change from baseline in heart rate

    Time frame: Baseline, after 6 weeks

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

Post-Marketing Surveillance Study Micardis® Plus

Important dates

Study start
2002
Primary completion
2002
First posted
Sep 12, 2014
Registry last updated
Sep 12, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.